https://www.taxtmi.com/article/detailed?id=13990 Imposing tariffs on imported Indian pharmaceuticals would raise prices for consumers and government purchasers, undermine drug affordability, and risk worsening health outcomes for populations dependent on low-cost generics. Tariffs could reduce U.S. supply availability as manufacturers redirect exports, exacerbate shortages or market concentration, and invite reciprocal trade measures that affect broader bilateral trade relations. Policymakers must weigh protective trade objectives against public-health, healthcare budgetary, and supply-stability consequences when considering tariffs on pharmaceutical imports. en-us Wed, 02 Apr 2025 08:58:55 +0530 Wed, 02 Apr 2025 08:58:55 +0530 TaxTMI RSS Generator https://www.taxtmi.com/article/detailed?id=13990 Imposing tariffs on imported Indian pharmaceuticals would raise prices for consumers and government purchasers, undermine drug affordability, and risk worsening health outcomes for populations dependent on low-cost generics. Tariffs could reduce U.S. supply availability as manufacturers redirect exports, exacerbate shortages or market concentration, and invite reciprocal trade measures that affect broader bilateral trade relations. Policymakers must weigh protective trade objectives against public-health, healthcare budgetary, and supply-stability consequences when considering tariffs on pharmaceutical imports. Articles Other Topics Wed, 02 Apr 2025 08:58:55 +0530 https://www.taxtmi.com/article/detailed?id=13990